$15,000 to be funded July 1, 2015 – June 30, 2016

The Role of a Comprehensive Cardiovascular Risk Reduction Program in Women with Breast Cancer Receiving Cardiotoxic Chemotherapy

• Michael Fradley, MD, Assistant Professor, Morsani College of Medicine
• Roohi Ismail-Khan, MD, Assistant Professor, H. Lee Moffitt Cancer Center & Research Institute
• Marcus Kilpatrick, PhD, Associate Professor, College of Education
• Theresa Beckie, PhD, MN, RN, FAHA, Professor, College of Nursing

Description:

Breast cancer is the most common cancer in women, and many treatment modalities have cardiovascular toxicities which can prevent completion of therapy.  We have proposed a multidisciplinary cardiovascular risk reduction program for women receiving chemotherapy for breast cancer.  The goals of this study are to prevent the serious cardiotoxic side-effects of chemotherapy and improve quality of life.